Last reviewed · How we verify
TDM-180935 topical ointment 2.0% — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
TDM-180935 topical ointment 2.0% (TDM-180935 topical ointment 2.0%) — Technoderma Medicines Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| TDM-180935 topical ointment 2.0% TARGET | TDM-180935 topical ointment 2.0% | Technoderma Medicines Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- TDM-180935 topical ointment 2.0% CI watch — RSS
- TDM-180935 topical ointment 2.0% CI watch — Atom
- TDM-180935 topical ointment 2.0% CI watch — JSON
- TDM-180935 topical ointment 2.0% alone — RSS
Cite this brief
Drug Landscape (2026). TDM-180935 topical ointment 2.0% — Competitive Intelligence Brief. https://druglandscape.com/ci/tdm-180935-topical-ointment-2-0. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab